Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2012, Article ID 970525, 7 pages
http://dx.doi.org/10.1155/2012/970525
Research Article

Peroxisome Proliferator-Activated Receptor α Plays an Important Role in the Expression of Monocyte Chemoattractant Protein-1 and Neointimal Hyperplasia after Vascular Injury

Department of Cardiovascular Medicine, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, China

Received 17 February 2012; Revised 7 May 2012; Accepted 8 May 2012

Academic Editor: Paul Drew

Copyright © 2012 Yu Peng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Libby and P. Ganz, “Restenosis revisited—new targets, new therapies,” The New England Journal of Medicine, vol. 337, no. 6, pp. 418–419, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Fuster, M. Poon, and J. T. Willerson, “Learning from the transgenic mouse: endothelium, adhesive molecules, and neointimal formation,” Circulation, vol. 97, no. 1, pp. 16–18, 1998. View at Google Scholar · View at Scopus
  4. B. Desvergne and W. Wahli, “Peroxisome proliferator-activated receptors: nuclear control of metabolism,” Endocrine Reviews, vol. 20, no. 5, pp. 649–688, 1999. View at Google Scholar · View at Scopus
  5. B. P. Neve, J. C. Fruchart, and B. Staels, “Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis,” Biochemical Pharmacology, vol. 60, no. 8, pp. 1245–1250, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. B. M. Forman, J. Chen, and R. M. Evans, “Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 9, pp. 4312–4317, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Delerive, J. C. Fruchart, and B. Staels, “Peroxisome proliferator-activated receptors in inflammation control,” Journal of Endocrinology, vol. 169, no. 3, pp. 453–459, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Delerive, K. De Bosscher, S. Besnard et al., “Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1,” The Journal of Biological Chemistry, vol. 274, no. 45, pp. 32048–32054, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Staels, W. Koenig, A. Habib et al., “Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators,” Nature, vol. 393, no. 6687, pp. 790–793, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. S. M. Jackson, F. Parhami, X. P. Xi et al., “Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 9, pp. 2094–2104, 1999. View at Google Scholar · View at Scopus
  11. N. Marx, G. K. Sukhova, T. Collins, P. Libby, and J. Plutzky, “PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells,” Circulation, vol. 99, no. 24, pp. 3125–3131, 1999. View at Google Scholar · View at Scopus
  12. C. W. Kopp, T. Hölzenbein, S. Steiner et al., “Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity,” Blood, vol. 103, no. 5, pp. 1653–1661, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. H. Morrissey, H. Fakhrai, and T. S. Edgington, “Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade,” Cell, vol. 50, no. 1, pp. 129–135, 1987. View at Google Scholar · View at Scopus
  14. J. D. Marmur, M. Rossikhina, A. Guha et al., “Tissue factor is rapidly induced in arterial smooth muscle after balloon injury,” The Journal of Clinical Investigation, vol. 91, no. 5, pp. 2253–2259, 1993. View at Google Scholar · View at Scopus
  15. M. S. Penn and E. J. Topol, “Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling,” Circulation Research, vol. 89, no. 1, pp. 1–2, 2001. View at Google Scholar · View at Scopus
  16. F. N. Ko, Y. C. Yang, S. C. Huang, and J. T. Ou, “Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat,” The Journal of Clinical Investigation, vol. 98, no. 6, pp. 1493–1501, 1996. View at Google Scholar · View at Scopus
  17. N. H. M. Senden, T. M. A. A. Jeunhomme, J. W. M. Heemskerk et al., “Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells,” Journal of Immunology, vol. 161, no. 8, pp. 4318–4324, 1998. View at Google Scholar · View at Scopus
  18. N. Marx, N. Mackman, U. Schönbeck et al., “PPARα activators inhibit tissue factor expression and activity in human monocytes,” Circulation, vol. 103, no. 2, pp. 213–219, 2001. View at Google Scholar · View at Scopus
  19. F. Gizard, C. Amant, O. Barbier et al., “PPARα inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a,” The Journal of Clinical Investigation, vol. 115, no. 11, pp. 3228–3238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Gizard, T. Nomiyama, Y. Zhao et al., “The PPARα/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation,” Circulation Research, vol. 103, no. 10, pp. 1155–1163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Ott, E. G. Fischer, Y. Miyagi, B. M. Mueller, and W. Ruf, “A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280,” Journal of Cell Biology, vol. 140, no. 5, pp. 1241–1253, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. A. D. Schecter, B. J. Rollins, Y. J. Zhang et al., “Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells,” The Journal of Biological Chemistry, vol. 272, no. 45, pp. 28568–28573, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. P. L. A. Giesen, B. S. Fyfe, J. T. Fallon et al., “Intimal tissue factor activity is released from the arterial wall after injury,” Thrombosis and Haemostasis, vol. 83, no. 4, pp. 622–628, 2000. View at Google Scholar · View at Scopus
  24. R. T. Pyo, Y. Sato, N. Mackman, and M. B. Taubman, “Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration,” Thrombosis and Haemostasis, vol. 92, no. 3, pp. 451–458, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. B. P. Neve, D. Corseaux, G. Chinetti et al., “PPARα agonists inhibit tissue factor expression in human monocytes and macrophages,” Circulation, vol. 103, no. 2, pp. 207–212, 2001. View at Google Scholar · View at Scopus
  26. P. Delerive, F. Martin-Nizard, G. Chinetti et al., “Peroxisome proliferator-activated receptor activators inhibit thrombin- induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway,” Circulation Research, vol. 85, no. 5, pp. 394–402, 1999. View at Google Scholar · View at Scopus
  27. M. Z. Cui, M. S. Penn, and G. M. Chisolm, “Native and oxidized low density lipoprotein induction of tissue factor gene expression in smooth muscle cells is mediated by both Egr-1 and Sp1,” The Journal of Biological Chemistry, vol. 274, no. 46, pp. 32795–32802, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Z. Cui, G. C. N. Parry, P. Oeth et al., “Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1,” The Journal of Biological Chemistry, vol. 271, no. 5, pp. 2731–2739, 1996. View at Publisher · View at Google Scholar · View at Scopus